TD Cowen downgraded Illumina to Market Perform from Outperform with a $144 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ILMN:
- SHAREHOLDER ALERT: Potential Recovery for Illumina, Inc. (ILMN) Investors
- SomaLogic sent letter to stockholders on transaction with Standard BioTools
- Early notable gainers among liquid option names on December 20th
- Amgen upgraded, PepsiCo downgraded: Wall Street’s top analyst calls
- Illumina price target lowered to $258 from $260 at RBC Capital